Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer

被引:256
|
作者
Zhu, Xinxin [1 ]
Lang, Jinghe [1 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China
关键词
soluble; PD-1; PD-L1; tumor immunity; biomarker; CELL LUNG-CANCER; DEATH-LIGAND; PROGRAMMED DEATH-1; ANTITUMOR IMMUNITY; T-CELLS; HEPATOCELLULAR-CARCINOMA; CLINICAL-SIGNIFICANCE; POOR-PROGNOSIS; PD-1/PD-L1; BLOCKADE; CIRCULATING PD-L1;
D O I
10.18632/oncotarget.18311
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The membrane-bound molecules programmed death 1 (PD-1) and its ligand PD-L1 (PD-1/PD-L1) belong to the immune checkpoint pathway. PD-1 pathway downregulates effector T cells in immune response, thereby causing immune suppression. Recent studies have revealed that membrane-bound PD-1 and PD-L1 also have soluble forms. These soluble forms increase the complexity and diversity of the composition and function of the PD-1/PD-L1 signaling pathway. However, the exact roles of these molecules remain unknown. The objective of this systematic review was to elucidate the biological significance of soluble PD-1/PD-L1 in human cancers and evaluate whether they are potential diagnostic, therapeutic, or prognostic biomarkers. We expect to provide new clues for future research on soluble PD-1/PD-L1 pathway in human malignant tumors.
引用
收藏
页码:97671 / 97682
页数:12
相关论文
共 50 条
  • [1] The clinical significance of soluble PD-1 and PD-L1 in lung cancer
    Abu Hejleh, Taher
    Furqan, Muhammad
    Ballas, Zuhair
    Clamon, Gerald
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 143 : 148 - 152
  • [2] Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer
    Niu, Mengke
    Liu, Yiming
    Yi, Ming
    Jiao, Dechao
    Wu, Kongming
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [3] Prognostic significance of soluble PD-L1 in prostate cancer
    Zvirble, Margarita
    Survila, Zilvinas
    Bosas, Paulius
    Dobrovolskiene, Neringa
    Mlynska, Agata
    Zaleskis, Gintaras
    Jursenaite, Jurgita
    Characiejus, Dainius
    Pasukoniene, Vita
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [4] Clinical and prognostic significance of PD-1 and PD-L1 expression in sarcomas
    Semra Paydas
    Emine Kilic Bagir
    Mehmet Ali Deveci
    Gulfiliz Gonlusen
    Medical Oncology, 2016, 33
  • [5] Clinical and prognostic significance of PD-1 and PD-L1 expression in sarcomas
    Paydas, Semra
    Bagir, Emine Kilic
    Deveci, Mehmet Ali
    Gonlusen, Gulfiliz
    MEDICAL ONCOLOGY, 2016, 33 (08)
  • [6] PD-1 and PD-L1 prognostic in UTUC
    Louise Stone
    Nature Reviews Urology, 2017, 14 : 518 - 518
  • [7] PD-1 and PD-L1 prognostic in UTUC
    Stone, Louise
    NATURE REVIEWS UROLOGY, 2017, 14 (09) : 518 - 518
  • [8] Measurement of soluble PD-1 and soluble PD-L1 as well as PD-L1 and PD-1 from perioperative patients with gastric carcinoma
    Wei, Hangzhi
    Wu, Fahong
    Mao, Yudong
    Zhang, Youcheng
    Leng, Guangxian
    Wang, Jia
    Zhang, Wei
    Wang, Tianwei
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2022, 52 (04) : 331 - 345
  • [9] Soluble PD-L1 levels correlate with efficacy of PD-1/PD-L1 inhibitors in lung cancer
    Kang, Da Hyun
    Koh, Jeong Suk
    Chung, Chaeuk
    Park, Dongil
    Lee, Song-I
    Lee, Jeong Eun
    RESPIROLOGY, 2023, 28 : 99 - 99
  • [10] SIGNIFICANCE OF PD-1 AND PD-L1 EXPRESSION IN OVARIAN CANCER BIOLOGY
    Wieser, V.
    Gaugg, I.
    Fleischer, M.
    Giridhar, S.
    Wenzel, S.
    Sprung, S.
    Lax, S.
    Zeimet, A.
    Fiegl, H.
    Marth, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 555 - 555